Issue 6/1997
Content (16 Articles)
A lymphoma cell line resistant to 4-piperidinopiperidine was less sensitive to CPT-11
Y. Onishi, Masao Oguro, Harutoshi Kizaki
Response of sensitive and resistant IgM immunocytomas to cis-diamminedichloroplatinum(II) does not correlate with the platination level or with the formation or removal of DNA adducts
Cornelis P. J. Vendrik, Anne Marie J. Fichtinger-Schepman, Wilhelmina C. M. van Dijk-Knijnenburg, W. H. de Jong, Anke C. E. van der Minnen, Gerard de Groot, Geert Frits Berends, P. A. Steerenberg
Preclinical antitumor activity of water-soluble paclitaxel derivatives
William C. Rose, John L. Clark, Francis Y. F. Lee, Anna Maria Casazza
Isolation and structural confirmation of N-desmethyl topotecan, a metabolite of topotecan
H. Rosing, V. M. M. Herben, D. M. Gortel-van Zomeren, E. Hop, J. J. Kettenes-van den Bosch, W. W. Bokkel Huinink, J. H. Beijnen
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers
David S. Alberts, Paul T. Fanta, Kelli L. Running, Laurence P. Adair Jr., Dava J. Garcia, Rosa Liu-Stevens, Sydney E. Salmon
Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat
B. J. Cusack, Stephan P. Young, Robert E. Vestal, Richard D. Olson
Tissue distribution of transdermal toremifene
L. Soe, Gregory T. Wurz, Juhani U. Mäenpää, Gene B. Hubbard, Timothy B. Cadman, Valerie J. Wiebe, Alain P. Theon, M. W. DeGregorio
Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostasis
John L. Tonkinson, Philip Marder, Sherri L. Andis, Richard M. Schultz, Lynn S. Gossett, Chuan Shih, L. G. Mendelsohn
Preclinical pharmacokinetics of β-L-dioxolane-cytidine, a novel anticancer agent, in rats
Laura E. Moore, F. D. Boudinot, Chung K. Chu
Adrenal proteins bound by a reactive intermediate of mitotane
W. Cai, Raymond E. Counsell, David E. Schteingart, J. E. Sinsheimer, Alfin D. N. Vaz, Linda L. Wotring
High-dose toremifene in advanced renal-cell carcinoma
Michael M. Gershanovich, Vladimir M. Moiseyenko, Andrey V. Vorobjev, Hannu Käpylä, Juha Ellmén, Markku Anttila
Interference by antifolate drugs in a folate competitive protein-binding assay
Anthea Hardcastle, Stephen Clarke, W. Aherne
Mechanisms of enhancement of the antitumour activity of melphalan by the tumour-blood-flow inhibitor 5,6-dimethylxanthenone-4-acetic acid
Frederik B. Pruijn, M. van Daalen, Nicholas H. G. Holford, W. R. Wilson
Plasma concentrations of polysorbate 80 measured in patients following administration of docetaxel or etoposide
L. K. Webster, Martha E. Linsenmeyer, Danny Rischin, Maureen E. Urch, David M. Woodcock, Michael J. Millward
Pharmacokinetics and tissue distribution of idarubicin and its active metabolite idarubicinol in the rabbit
M. Looby, R. Linke, M. Weiss
Effect of ifosfamide on intracellular glutathione levels in peripheral blood lymphocytes and its correlation with therapeutic response in patients with advanced ovarian cancer
I. A. Malik, Naseema Mehboobali, M. Perwaiz Iqbal